References
- Makishima H, Nannya Y, Takeda J, et al. Clinical impacts of germline DDX41 mutations on myeloid neoplasms. Blood. 2020;136(Supplement 1):38–40. doi: 10.1182/blood-2020-140174
- Rio-Machin A, Fitzgibbon J. DDX41: the poster child for familial AML. Blood. 2022;140(7):667–669. doi: 10.1182/blood.2022016598
- Feurstein S, Trottier AM, Estrada-Merly N, et al. Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages. Blood. 2022;140(24):2533–2548. doi: 10.1182/blood.2022015790
- Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn ed. Lyon, France: International Agency for Research on Cancer; 2017.
- Khoury JD, Solary E, Abla O, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703–1719. doi: 10.1038/s41375-022-01613-1
- Arber DA, Orazi A, Hasserjian RP, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200–1228. doi: 10.1182/blood.2022015850
- Hamidi A, Roloff G, Shaw R, et al. Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes. Leuk Lymphoma. 2023;:1–4. doi: 10.1080/10428194.2023.2220457
- Berger G, van den Berg E, Sikkema-Raddatz B, et al. Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation. Leukemia. 2017;31(2):520–522. doi: 10.1038/leu.2016.310
- Baliakas P, Tesi B, Wartiovaara-Kautto U, et al. Nordic guidelines for germline predisposition to myeloid neoplasms in adults: recommendations for genetic diagnosis, clinical management and follow-up. Hemasphere. 2019;3(6):e321. doi: 10.1097/HS9.0000000000000321
- Rojek K, Nickels E, Neistadt B, et al. Identifying inherited and acquired genetic factors involved in poor stem cell mobilization and donor-derived malignancy. Biol Blood Marrow Transplant. 2016;22(11):2100–2103. doi: 10.1016/j.bbmt.2016.08.002
- Saygin C, Roloff G, Hahn CN, et al. Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies. Blood Adv. 2023;7(4):549–554. doi: 10.1182/bloodadvances.2022008172